PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 9862447-6 1998 Long-term incubation (24 h) of mesangial cells with TPA, which downregulates PKC-alpha, -delta, and -epsilon isoenzymes, resulted in a recovery of IL-1beta-stimulated neutral SMase activity as well as ceramide formation. Tetradecanoylphorbol Acetate 52-55 interleukin 1 beta Rattus norvegicus 147-155 11199339-1 2000 Production of interleukin (IL)-1 beta, IL-6 and tumor necrosis factor (TNF)-alpha by rat corneal epithelial cells in response to lipopolysaccharide and phorbol-12-myristate-13-acetate (PMA) was tested. Tetradecanoylphorbol Acetate 152-183 interleukin 1 beta Rattus norvegicus 14-37 10571249-3 1999 We found that treatment of mesangial cells with the biologically active phorbol 12-myristate 13-acetate (PMA) and phorbol 12,13-dibutyrate inhibited IL-1beta induction of sPLA2-IIA mRNA, protein, and activity, whereas the inactive compound 4alpha-phorbol 12,13-didecanoate was without effect. Tetradecanoylphorbol Acetate 72-103 interleukin 1 beta Rattus norvegicus 149-157 10571249-3 1999 We found that treatment of mesangial cells with the biologically active phorbol 12-myristate 13-acetate (PMA) and phorbol 12,13-dibutyrate inhibited IL-1beta induction of sPLA2-IIA mRNA, protein, and activity, whereas the inactive compound 4alpha-phorbol 12,13-didecanoate was without effect. Tetradecanoylphorbol Acetate 105-108 interleukin 1 beta Rattus norvegicus 149-157 10571249-5 1999 Only after down-regulation of PKC-epsilon isoenzyme by 24-hr preincubation with PMA were we able to reconstitute the IL-1beta-induced sPLA2-IIA expression. Tetradecanoylphorbol Acetate 80-83 interleukin 1 beta Rattus norvegicus 117-125 7722482-4 1995 This stimulatory action of phorbol 12-myristate 13-acetate was significantly reduced by staurosporine, by calphostin C and by the desensitization of protein kinase C. Interleukin 1 beta increased interleukin 6 release in a concentration-related manner. Tetradecanoylphorbol Acetate 27-58 interleukin 1 beta Rattus norvegicus 167-185 7586373-10 1995 Phorbol 12-myristate 13-acetate (PMA) also augmented NO synthesis in IL-1 beta-stimulated but not in unstimulated cells in a dose-dependent manner. Tetradecanoylphorbol Acetate 0-31 interleukin 1 beta Rattus norvegicus 69-78 7586373-10 1995 Phorbol 12-myristate 13-acetate (PMA) also augmented NO synthesis in IL-1 beta-stimulated but not in unstimulated cells in a dose-dependent manner. Tetradecanoylphorbol Acetate 33-36 interleukin 1 beta Rattus norvegicus 69-78 8079811-4 1994 Peritoneal administration of IL-1 beta caused elicitation of cells which were enriched in eosinophils; however, the functional responses of the cells in all three groups were broadly similar in terms of the ability of the agonists FMLP, PMA and A23187 to initiate superoxide generation, beta-glucuronidase secretion and leukotriene generation. Tetradecanoylphorbol Acetate 237-240 interleukin 1 beta Rattus norvegicus 29-38 7526844-3 1994 Here we report that addition of the biologically active phorbol esters, phorbol 12-myristate 13-acetate (PMA) and phorbol 12,13-dibutyrate (PDBu), dose-dependently inhibited the IL-1 beta-stimulated increase in iNOS mRNA levels and nitrite production. Tetradecanoylphorbol Acetate 72-103 interleukin 1 beta Rattus norvegicus 178-187 7526844-3 1994 Here we report that addition of the biologically active phorbol esters, phorbol 12-myristate 13-acetate (PMA) and phorbol 12,13-dibutyrate (PDBu), dose-dependently inhibited the IL-1 beta-stimulated increase in iNOS mRNA levels and nitrite production. Tetradecanoylphorbol Acetate 105-108 interleukin 1 beta Rattus norvegicus 178-187 8035171-2 1994 Treatment of astrocytes with interleukin-1 beta (IL-1) or the protein kinase C (PKC) activator 12-O-tetradecanoylphorbol 13-acetate (TPA) increased NGF mRNA content by six- to 10-fold, followed in time by increases in cell content and cell secretion of NGF. Tetradecanoylphorbol Acetate 133-136 interleukin 1 beta Rattus norvegicus 29-47 8395530-4 1993 Pretreatment of the cells with TPA (10(-7) M) abolished the subsequent response to IL-1 beta, TGF-alpha, and EGF and at the same time resulted in > 90% reduction of cytosolic protein kinase C activity. Tetradecanoylphorbol Acetate 31-34 interleukin 1 beta Rattus norvegicus 83-92 1907704-5 1991 The secretion of FSH and LH mediated by an activator of protein kinase C, phorbol 12-myristate 13-acetate, was also significantly suppressed by pretreatment with IL-1 beta for 48 hr. Tetradecanoylphorbol Acetate 74-105 interleukin 1 beta Rattus norvegicus 162-171 23775412-5 2013 The expression of PAR4 in cultured DRG neurons was also assessed after treatment with IL-1beta with pre-addition of phorbol-12-myristate 13-acetate (PMA, a PKC activator) or chelerythrine chloride (a PKC inhibitor). Tetradecanoylphorbol Acetate 116-147 interleukin 1 beta Rattus norvegicus 86-94 23775412-8 2013 This IL-1beta effect was enhanced in DRG neurons when DRG cultures were pre-treatment with the PMA. Tetradecanoylphorbol Acetate 95-98 interleukin 1 beta Rattus norvegicus 5-13